scholarly journals Targeting ferritin receptors for the selective delivery of imaging and therapeutic agents to breast cancer cells

Nanoscale ◽  
2015 ◽  
Vol 7 (15) ◽  
pp. 6527-6533 ◽  
Author(s):  
S. Geninatti Crich ◽  
M. Cadenazzi ◽  
S. Lanzardo ◽  
L. Conti ◽  
R. Ruiu ◽  
...  

Horse Spleen Apoferritin has been exploited to deliver simultaneously therapeutic and imaging agents to breast cancer cells via the ferritin transporting route. The selective uptake has been investigated by MRI, and exploited for the simultaneous delivery of Curcumin, a compound with strong anti-neoplastic and anti-inflammatory action.

ACS Omega ◽  
2017 ◽  
Vol 2 (12) ◽  
pp. 8730-8740 ◽  
Author(s):  
Sandeep Palvai ◽  
Libi Anandi ◽  
Sujit Sarkar ◽  
Meera Augustus ◽  
Sudip Roy ◽  
...  

2013 ◽  
Vol 1 (39) ◽  
pp. 5288 ◽  
Author(s):  
Hang Xing ◽  
Li Tang ◽  
Xujuan Yang ◽  
Kevin Hwang ◽  
Wendan Wang ◽  
...  

Author(s):  
Daniel Gabriel Pons ◽  
Margalida Torrens-Mas ◽  
Mercedes Nadal-Serrano ◽  
Jorge Sastre-Serra ◽  
Pilar Roca ◽  
...  

2015 ◽  
Vol 93 (5) ◽  
pp. 333-348 ◽  
Author(s):  
Yotaro Matsumoto ◽  
Atsushi Kittaka ◽  
Tai C. Chen

The active form of vitamin D3, 1α,25-dihydroxyvitamin D3 (1α,25(OH)2D3 or calcitriol), is known to inhibit the proliferation and invasiveness of many types of cancer cells, including breast, colon, pancreatic, prostate, and liver cancer cells. These findings support the use of 1α,25(OH)2D3 for the treatment of these types of cancer. However, 1α,25(OH)2D3 can cause hypercalcemia, so analogs of 1α,25(OH)2D3 that are less calcemic but exhibit more potent anti-tumor activity would be good candidates as therapeutic agents. Therefore, a series of 19-norvitamin D analogs, in which the methylidene group on C19 is replaced with 2 hydrogen atoms, have been synthesized by several laboratories. In our laboratory, we have designed and synthesized a series of 2α-functional group substituted 19-norvitamin D3 analogs and examined their anti-proliferative activity. Among them, 2α- and 2β-(3-hydroxypropyl)-1α,25-dihydroxy-19-norvitamin D3 (MART-10 and MART-11) were found to be the most promising. Here, we review the rationale and approaches for the synthesis of different 19-norvitamin D analogs, and the pre-clinical studies using these analogs in breast cancer cells, in particular, we chose MART-10 for its potential application to the prevention and treatment of breast cancer.


2019 ◽  
Vol Volume 14 ◽  
pp. 2619-2636 ◽  
Author(s):  
Mahdi Rahimi ◽  
Ramin Karimian ◽  
Ehsan Bahojb Noruzi ◽  
Khudaverdi Ganbarov ◽  
Mojtaba Zarei ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document